Antihypertensive Drugs Pocket Card 2026 (High Blood Pressure Medicines)

An updated pocket card on antihypertensive medicines for pharmacy and medical students: BP categories and targets, when to start treatment, first-line drugs and doses, step-wise therapy, compelling indications and side effects, based on the 2025 AHA/ACC High Blood Pressure Guideline.

Antihypertensive Drugs Pocket Card 2026
High blood pressure in adults · based on 2025 AHA/ACC guideline
A ACE inhibitor or ARB   C calcium channel blocker   D thiazide-type diuretic (the three first-line groups)  |  OD = once daily · BD = twice daily · BP in mmHg
BP categories & targets
  • Normal: under 120 and under 80
  • Elevated: 120 to 129 and under 80
  • Stage 1: 130 to 139 or 80 to 89
  • Stage 2: 140 or more, or 90 or more
  • Crisis: 180 or more and/or 120 or more
  • Target: under 130/80 for most adults; aim for systolic under 120 if tolerated
  • Diagnosis: confirm with home or 24-h BP; average of 2 or more readings on 2 or more visits
When to start medicine
  • Stage 2: lifestyle + start 2 first-line drugs, preferably one single pill
  • Stage 1 + high risk: start one drug now if CVD, diabetes, CKD or 10-year PREVENT risk 7.5% or more
  • Stage 1 + lower risk: lifestyle for 3 to 6 months; start a drug if still 130/80 or more
  • Elevated: lifestyle only
  • Follow-up: monthly until at goal, then every 3 to 6 months
  • Before adding drugs: check adherence, home BP and interfering drugs (NSAIDs, decongestants, steroids, oral contraceptives)
First-line drugs (adult daily doses)
  • A ACE inhibitors: lisinopril 10 to 40 mg OD; ramipril 2.5 to 10 mg OD; enalapril 5 to 40 mg OD/BD; perindopril 4 to 8 mg OD
  • A ARBs: losartan 50 to 100 mg; valsartan 80 to 320 mg; telmisartan 40 to 80 mg; irbesartan 150 to 300 mg; olmesartan 20 to 40 mg; candesartan 8 to 32 mg
  • C Dihydropyridine CCB: amlodipine 2.5 to 10 mg OD; nifedipine LA 30 to 90 mg OD
  • D Thiazide-type: chlorthalidone 12.5 to 25 mg OD; indapamide SR 1.5 mg OD; hydrochlorothiazide 25 to 50 mg OD
  • Never: combine an ACE inhibitor with an ARB (or with aliskiren)
Step-wise treatment
  • Step 1: one drug (A, C or D) for stage 1; or A+C or A+D single pill for stage 2
  • Step 2: A + C + D (triple therapy, ideally one pill)
  • Step 3: resistant HTN: add spironolactone 12.5 to 50 mg (if potassium under 4.5 and eGFR 45 or more); screen for primary aldosteronism
  • Step 4: beta-blocker, alpha-blocker (doxazosin), clonidine or hydralazine; refer to specialist
  • Obesity: add a GLP-1 based drug for weight loss; it also lowers BP
Compelling indications
  • Diabetes with albuminuria / CKD: A first (max tolerated dose); add SGLT2 inhibitor
  • Heart failure (HFrEF): ACEi/ARB/ARNI + beta-blocker (bisoprolol, carvedilol, metoprolol succinate) + MRA + SGLT2 inhibitor; avoid diltiazem and verapamil
  • After heart attack / angina: beta-blocker + ACEi or ARB
  • Atrial fibrillation: beta-blocker or diltiazem/verapamil for rate control
  • Black patients: start with C or D
  • Pregnancy: labetalol, nifedipine LA or methyldopa; never ACEi, ARB or spironolactone
Side effects & monitoring
  • ACE inhibitors: dry cough (switch to ARB), angioedema, high potassium, creatinine rise; check K and creatinine 1 to 2 weeks after starting (rise up to 30% is acceptable)
  • ARBs: as ACEi but no cough
  • Amlodipine / nifedipine: ankle swelling (not helped by diuretics), flushing, headache, gum overgrowth
  • Diltiazem / verapamil: slow heart rate, constipation; avoid with beta-blockers and in HFrEF
  • Thiazides: low potassium and sodium, high uric acid (gout), high glucose; check electrolytes
  • Beta-blockers: tiredness, slow heart rate, cold hands, hide hypo signs; avoid non-selective ones in asthma
  • Spironolactone: high potassium, breast enlargement in men
  • Triple whammy: ACEi/ARB + diuretic + NSAID can cause acute kidney injury
Typical adult doses. Hypertensive emergency (BP 180/120 or more with organ damage) needs hospital IV treatment; lower BP by no more than 25% in the first hour. Do not use sublingual nifedipine. Always follow local guidelines and the prescriber. Source: 2025 AHA/ACC High Blood Pressure Guideline.

Details behind the card

1. What changed in the 2025 AHA/ACC guideline?

  • BP categories are the same as 2017, and the target stays under 130/80, with encouragement to reach systolic under 120 if tolerated.
  • A new risk calculator, PREVENT, decides who with stage 1 hypertension needs medicine straight away (risk 7.5% or more).
  • Stage 2: start with two first-line drugs, preferably in a single pill, for better adherence and faster control.
  • Urine albumin (uACR) should be tested in everyone with hypertension.
  • Primary aldosteronism screening is advised more widely, especially in resistant hypertension.
  • Good BP control also lowers the risk of dementia and memory decline.
  • GLP-1 based medicines can be used in people with high BP and obesity.

2. Lifestyle: how much BP falls

ChangeGoalSystolic fall (approx.)
Weight losslose weight if overweightabout 1 mmHg per kg lost
DASH-type dietfruit, vegetables, low-fat dairy, whole grains, less saturated fatabout 11 mmHg
Less saltsodium under 1,500 mg/day, or at least 1,000 mg less than now5 to 6 mmHg
More potassiumfrom food (fruit, vegetables), unless kidney disease4 to 5 mmHg
Exercise150 min/week moderate aerobic, plus resistance training5 to 8 mmHg
Alcoholavoid, or keep to a minimumabout 4 mmHg

3. How to measure BP correctly

  • Sit quietly for 5 minutes, back supported, feet flat, arm supported at heart level.
  • No caffeine, smoking or exercise for 30 minutes before.
  • Use the right cuff size; a small cuff gives a falsely high reading.
  • Take 2 readings 1 minute apart and use the average.
  • Home BP: 2 readings morning and evening for a week. Home BP of 130/80 or more equals office hypertension.
  • White-coat hypertension: high in clinic, normal at home. Masked hypertension: normal in clinic, high at home.

4. Antihypertensive classes at a glance

ClassHow it worksBest forAvoid / caution
ACE inhibitors (-pril)Block angiotensin II formationDiabetes, CKD with albuminuria, heart failure, after MIPregnancy, angioedema history, bilateral renal artery stenosis
ARBs (-sartan)Block angiotensin II receptorAs ACEi; ACEi coughPregnancy; never with ACEi
Dihydropyridine CCBsRelax artery muscleElderly, Black patients, anginaAnkle oedema
Thiazide-type diureticsKidneys pass more salt and waterElderly, Black patients, osteoporosisGout, low potassium or sodium
Beta-blockers (-olol)Slow heart, reduce reninHeart failure, angina, after MI, AFAsthma (non-selective), heart block; not first-line alone
MRA (spironolactone, eplerenone)Block aldosteroneResistant HTN, heart failure, aldosteronismHigh potassium, eGFR under 30
Alpha-blockers (doxazosin)Relax blood vesselsMen with enlarged prostatePostural hypotension
Central (methyldopa, clonidine)Reduce nerve signals to vesselsPregnancy (methyldopa)Rebound BP if clonidine stopped suddenly

5. Hypertensive urgency vs emergency

  • Urgency: BP 180/120 or more without organ damage. Restart or add oral drugs and review within days; no need for rapid lowering.
  • Emergency: BP 180/120 or more with organ damage (chest pain, breathlessness, stroke signs, confusion, vision loss, kidney injury, eclampsia). Admit for IV drugs (labetalol, nicardipine, nitroglycerin).
  • Lower BP by no more than 25% in the first hour, then towards 160/100 over the next 2 to 6 hours. Faster lowering only for aortic dissection, severe pre-eclampsia or eclampsia.

6. Special groups

  • Elderly: same target if tolerated; start low, check for postural hypotension and falls.
  • Pregnancy: treat BP 140/90 or more; labetalol, nifedipine LA or methyldopa. Low-dose aspirin from 12 weeks for high-risk women to prevent pre-eclampsia.
  • Women planning pregnancy: switch away from ACEi and ARB before conception.
  • CKD: ACEi or ARB if albuminuria; loop diuretic (furosemide) when eGFR is under 30 and fluid overload is present.

Remember for exams

  • First-line groups: ACEi/ARB, CCB, thiazide-type diuretic.
  • Target under 130/80; stage 2 starts with two drugs in one pill.
  • ACEi cough: switch to ARB. Never combine ACEi with ARB.
  • ACEi/ARB contraindicated in pregnancy; use labetalol, nifedipine or methyldopa.
  • Resistant hypertension: add spironolactone and screen for primary aldosteronism.
  • Emergency: lower by no more than 25% in the first hour.

Sources

  • 2025 AHA/ACC/Multisociety Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation / Hypertension / JACC, August 2025.
  • 2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
  • NICE NG136: Hypertension in adults: diagnosis and management.
  • Product information (SmPC) for individual drugs.

Important: this card is for education and revision. Treatment decisions must follow local guidelines and the treating doctor. More pocket cards: Clinical Pocket Cards

No comments:

Post a Comment